Gharib M. Samir's Insider Trades & SAST Disclosures
Gharib M. Samir's most recent trade in Spruce Biosciences Inc was a trade of 154,000 Common Stock done . Disclosure was reported to the exchange on Dec. 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gharib M. Samir.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spruce Biosciences Inc | M. Samir Gharib | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 154,000 | 356,776 | - | 0 | Common Stock | |
| Spruce Biosciences Inc | Samir Gharib M. | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 154,000 | 154,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Gharib Samir M. | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. | 10 Dec 2024 | 54,948 | 301,828 | - | 0.5 | 29,507 | Common Stock |
| Spruce Biosciences Inc | Gharib M. Samir | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 38,500 | 115,500 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Gharib Samir M. | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 38,500 | 340,328 | - | 0 | Common Stock | |
| Spruce Biosciences Inc | M. Gharib Samir | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 37,250 | 74,500 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2024 | 37,250 | 363,841 | - | 0 | Common Stock | |
| Spruce Biosciences Inc | M. Gharib Samir | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 13,737 | 326,591 | - | 0.4 | 5,340 | Common Stock |
| Spruce Biosciences Inc | Gharib M. Samir | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 10 Dec 2024 | 13,291 | 350,550 | - | 0.4 | 5,166 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 154,000 | 154,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 29 Dec 2023 | 11,255 | 202,776 | - | 1.0 | 11,002 | Common Stock |
| Spruce Biosciences Inc | M. Samir Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 308,000 | 308,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Gharib M. Samir | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 75,000 | 190,366 | - | 0 | Common Stock | |
| Spruce Biosciences Inc | Samir Gharib M. | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 37,250 | 111,750 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | M. Samir Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 37,250 | 204,403 | - | 0 | Common Stock | |
| Spruce Biosciences Inc | Samir Gharib M. | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 23,213 | 167,153 | - | 1.7 | 38,534 | Common Stock |
| Spruce Biosciences Inc | Gharib M. Samir | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 14 Dec 2023 | 12,882 | 191,521 | - | 1.7 | 21,384 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 75,000 | 150,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 75,000 | 141,302 | - | - | Common Stock | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. | 30 Jun 2023 | 25,936 | 115,366 | - | 2.1 | 55,762 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.98 per share. | 30 Jun 2023 | 10,484 | 66,302 | - | 1.0 | 10,248 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 225,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 71,111 | - | - | Common Stock | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 03 Jan 2023 | 15,293 | 55,818 | - | 1.2 | 17,587 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 03 Jan 2023 | 1 | 33,611 | - | 1 | 1 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 149,000 | 149,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 37,500 | 262,500 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 37,500 | 41,132 | - | - | Common Stock | |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.74 per share. | 30 Jun 2022 | 12,968 | 33,610 | - | 1.7 | 22,564 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | President & CFO | Grant, award, or other acquisition of securities at price $ 1.48 per share. | 30 Jun 2022 | 5,446 | 46,578 | - | 1.5 | 8,055 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Spruce Biosciences Inc | Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 145,000 | 145,000 | - | - | Employee Stock Option (right to buy) | |
| Spruce Biosciences Inc | Samir M. Gharib | Chief Financial Officer | Other type of transaction at price $ 9.53 per share. | 30 Jun 2021 | 1,412 | 1,412 | - | 9.5 | 13,454 | Common Stock |
| Spruce Biosciences Inc | Samir M. Gharib | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges